Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Kerry Huntington counts out loud each punch she hurls at the speed bag in front of her, keeping her eyes trained on the ...

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...

Parkinson's disease often begins asymmetrically, affecting either the right or left side of the body first. Researchers from ...

A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly ...

Published today in the prestigious JAMA Neurology, this 12-month clinical trial involving 55 participants with Parkinson's ...

A groundbreaking new study out of Northwestern Medicine may offer new hope for the more than one million Americans living ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...